These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8059299

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Current status of viral safety of virus inactivated factor VIII and IX concentrates in treatment of hemophilia].
    Pollmann H.
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():80-3. PubMed ID: 8000261
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Successful clinical use of a plasma-derived, dual virus inactivated factor VII concentrate incorporating solvent-detergent and dry heat treatment.
    Smith MP, Rice KM, Savidge GF.
    Thromb Haemost; 1997 Feb; 77(2):406-7. PubMed ID: 9157608
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Blood safety and the choice of anti-hemophilic factor concentrate.
    Janco RL.
    Pediatr Blood Cancer; 2007 Jan; 48(1):117. PubMed ID: 17063470
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
    Santagostino E, Gringeri A, Tagliavacca L, Mannucci PM.
    Thromb Haemost; 1995 Aug; 74(2):619-21. PubMed ID: 8584995
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of factor VIII concentrates on the immune system of patients with hemophilia.
    Mannucci PM.
    Thromb Haemost; 1995 Jul; 74(1):437-9. PubMed ID: 8578501
    [Abstract] [Full Text] [Related]

  • 14. Therapy of factor VIII deficiency.
    Gill JC.
    Semin Thromb Hemost; 1993 Jul; 19(1):1-12. PubMed ID: 8456319
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Virus in hemophilia: current status and future perspectives].
    Aguilar C, Félix Lucía J.
    Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
    [No Abstract] [Full Text] [Related]

  • 17. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
    Baglin T, Beacham E.
    Thromb Haemost; 1998 Dec; 80(6):1036-7. PubMed ID: 9869186
    [No Abstract] [Full Text] [Related]

  • 18. Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
    Lethagen S.
    Semin Thromb Hemost; 2003 Feb; 29(1):101-6. PubMed ID: 12640572
    [Abstract] [Full Text] [Related]

  • 19. Cryoprecipitate revisited.
    Aledort LM.
    Transfusion; 1988 Feb; 28(4):295-6. PubMed ID: 3133841
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.